Danaher Corp DHR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Cytek Biosciences Shares Drop After Jury Says It Owes $56 Million in Damages
-
Danaher Up Over 6%, on Pace for Largest Percent Increase Since October 2025 — Data Talk
-
Danaher Down Over 14%, on Pace for Largest Percent Decrease Since October 1987 — Data Talk
-
Danaher Flags Slowing Growth Despite Strong 2Q — Update
-
Danaher Profit, Revenue Rise, Upgrades Full-Year Outlook
-
Leica Biosystems to Acquire StatLab Medical Products
-
Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains — Update
-
Danaher Raises Adjusted Earnings Guidance, 1Q Revenue, Profit Rise
Trading Information
- Previous Close Price
- MX$3,885.00
- Day Range
- MX$4,010.00–4,011.00
- 52-Week Range
- MX$2,795.00–4,273.97
- Bid/Ask
- MX$3,942.56 / MX$4,096.00
- Shares Outstanding
- 702.99M
- Market Cap
- $2.82T
- Volume/Avg
- 202 / 154
Key Statistics
- Price/Earnings (Normalized)
- 27.44
- Price/Sales
- 6.31
- Dividend Yield (Trailing)
- 0.67%
- Dividend Yield (Forward)
- 0.73%
- Dividend Payment Schedule
- Jan, Apr, Jul, Oct
- Total Yield
- 2.47%
Company Profile
In 1984, Danaher’s founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Large Value
- Total Number of Employees
- 60,000
- Website
- https://www.danaher.com
Competitors
Valuation
|
Metric
|
DHR
|
MRK
|
RHHBY
|
|---|---|---|---|
Price/Earnings (Normalized) | 27.44 | 17.09 | 19.13 |
Price/Book Value | 3.07 | 1.99 | 8.52 |
Price/Sales | 6.31 | 2.84 | 4.39 |
Price/Cash Flow | 22.11 | 13.17 | 13.75 |
Price/Earnings
DHR
MRK
RHHBY
Financial Strength
|
Metric
|
DHR
|
MRK
|
RHHBY
|
|---|---|---|---|
Quick Ratio | 1.03 | 0.99 | 0.80 |
Current Ratio | 1.65 | 1.69 | 1.23 |
Interest Coverage | 16.95 | 7.22 | 13.49 |
Quick Ratio
DHR
MRK
RHHBY
Profitability
|
Metric
|
DHR
|
MRK
|
RHHBY
|
|---|---|---|---|
Return on Assets (Normalized) | 5.34% | 4.75% | 15.81% |
Return on Equity (Normalized) | 8.59% | 8.32% | 48.77% |
Return on Invested Capital (Normalized) | 6.45% | 6.65% | 23.90% |
Return on Assets
DHR
MRK
RHHBY
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|#k?g^PXC | LOCK|q& | $243B | |||
| Danaher Corp
DHR
| LOCK|P#$!DwF | LOCK|@P? | $155B | |||
| Agilent Technologies Inc
A
| LOCK|>?&s#%TP | LOCK|NWb | $48B | |||
| IQVIA Holdings Inc
IQV
| LOCK|W&qv!G^ | LOCK|Ldh! | $43B | |||
| Waters Corp
WAT
| LOCK|%SGs^z | LOCK|$T | $43B | |||
| Illumina Inc
ILMN
| LOCK|#y@Qw<N | LOCK|$<<XN | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|?shL<k%> | LOCK|!z | $41B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|P^HZ%>&$ | LOCK|nSJ&h | $31B | |||
| Quest Diagnostics Inc
DGX
| LOCK|M%m@^c | LOCK|Hf#R | $25B | |||
| Labcorp Holdings Inc
LH
| LOCK|@@Zh<V%r | LOCK|dpG$P | $25B |
United States